A plan to end malaria in Africa

Observer

25-05-2025

Despite being preventable and curable, malaria has continued to claim African lives. In 2023, the continent accounted for around 95 per cent of the 597,000 deaths from malaria worldwide, 76 per cent of which were children under the age of five.
But eliminating this scourge, which impedes development goals and realisation of the African Union's Agenda 2063, is within reach. Nine AU member countries – Algeria, Cabo Verde, Egypt, Lesotho, Libya, Mauritius, Morocco, the Seychelles and Tunisia – have become malaria-free, owing to sustained political commitment and well-targeted public investment in primary healthcare and disease surveillance and case management. African countries with a higher malaria burden should heed their example.
Algeria, for example, invested in effective vector control through indoor residual spraying, universal healthcare access for malaria diagnosis and treatment, and rapid outbreak-response mechanisms. Cabo Verde's strategic malaria-elimination plan involved a multisectoral approach, whereby the government worked closely with local communities and international organisations. Egypt's multipronged strategy included, among other things, robust training programmes for primary health workers. Implementing these coordinated interventions required the political will and, crucially, increased domestic financing.
Overall, Africa's efforts to control malaria – particularly through the use of insecticide-treated nets, indoor spraying and seasonal chemoprevention (which involves giving children a monthly course of antimalarial medicines) – have driven a notable decline in malaria deaths on the continent, from 805,000 in 2000 to 569,000 in 2023. (The Covid-19 pandemic, coupled with the emergence of partial resistance to the well-established malaria medicine artemisinin, caused a brief uptick, to 598,000, in 2020.)
But these gains are fragile, particularly as new mosquito variants emerge, insecticide resistance grows, climate change worsens, humanitarian crises become more frequent, and, perhaps most importantly, the global malaria-funding gap widens. In 2023, only $4 billion was mobilised for malaria elimination, far below the $8.3 billion annual target, and a slight drop from the $4.1 billion raised in 2022. The problem is even more acute in Africa, where external health aid has declined by a whopping 70 per cent between 2021 and 2025. Moreover, most African countries devote less than 10 per cent of their national budgets to the health sector – well below the 15 per cent target set by the 2001 Abuja Declaration.
Given the uncertain future of foreign aid, African governments must recognise malaria as a development priority and invest more in efforts to control and eliminate it. That means leveraging untapped resources, including the more than $95 billion in annual remittances from the African diaspora. Innovative financing instruments such as diaspora bonds could support the continent's public-health agenda. Solidarity levies on tobacco, mobile transactions, and airline tickets could also generate billions of dollars for health services. And scaling up national health-insurance schemes will be required to expand access to malaria prevention, diagnosis and treatment.
Blended finance can unlock private capital for malaria-related research and development, as well as local manufacturing of therapeutics. With Africa's healthcare market projected to be worth $259 billion by 2030, policymakers should capitalise on this opportunity to create effective public-private partnerships, advance last-mile delivery solutions, and improve surveillance and vector control.
This would be an investment in Africa's present and future, because every dollar spent on malaria control and elimination generates a remarkable return of $36 in economic growth. A malaria-free population is more likely to access education and contribute to the continent's socioeconomic development. And let me be clear: investing in the fight to end malaria is not only a health and economic imperative; it is an act of justice. The disease disproportionately affects the poorest and most vulnerable Africans, perpetuating cycles of poverty and inequality.
Last year, I joined health ministers from 11 AU member countries with high malaria burdens in committing to accelerate efforts to reduce deaths from the disease. As part of the declaration, we agreed that 'no one should die from malaria given the tools and systems available.'
The task now is to take concrete action. The Africa Centers for Disease Control and Prevention (of which I am Director-General) is ready to help develop a continental strategy for ending malaria in Africa by 2040. By making smart investments, implementing well-targeted policies and deepening collaboration, we can ensure that all African countries become malaria-free within the coming generation. @Project Syndicate, 2025
Jean Kaseya
The writer is Director-General of the Africa Centers for Disease Control and Prevention